Testing effectiveness (Phase 2)Not Yet RecruitingNCT06338826
What this trial is testing
Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses
Who this might be right for
HIV InfectionsHBV Coinfection
ANRS, Emerging Infectious Diseases 140